Detalhe da pesquisa
1.
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
; 152(2): 308-319, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054558
2.
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 164(3): 607-616, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728779
3.
Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells.
Int J Mol Sci
; 23(9)2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563629
4.
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients.
Int J Mol Sci
; 23(15)2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35897674
5.
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study.
J Headache Pain
; 23(1): 55, 2022 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538414
6.
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Int J Cancer
; 148(7): 1695-1707, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113214
7.
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
J Neurooncol
; 152(2): 325-332, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502678
8.
Electrolyte and renal disorders in patients with newly diagnosed glioblastoma.
Future Oncol
; 17(34): 4711-4719, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672208
9.
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.
J Appl Clin Med Phys
; 22(1): 242-250, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389825
10.
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience.
J Headache Pain
; 22(1): 111, 2021 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544359
11.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782343
12.
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting.
Eur J Nucl Med Mol Imaging
; 47(6): 1435-1445, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811342
13.
Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
Epilepsia
; 61(4): 647-656, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329527
14.
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
J Neurooncol
; 148(3): 489-500, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535723
15.
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.
Int J Mol Sci
; 21(19)2020 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33003586
16.
Erenumab in highly therapy-refractory migraine patients: First German real-world evidence.
J Headache Pain
; 21(1): 84, 2020 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620151
17.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 20(10): 1444-1453, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488360
18.
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
J Transl Med
; 17(1): 96, 2019 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30894200
19.
Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report.
BMC Cancer
; 19(1): 995, 2019 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646997
20.
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J Neurooncol
; 144(3): 501-509, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325144